Heterozygous mutations in the IGF1R gene, causing partial resistance to IGF1, are associated with several metabolic and endocrine alterations such as hypo/hyperlipidemia, hypothyroidism, diabetes/insulin resistance or even hypoglycaemia (7–9). Here, IGF1R is linked to diabetes mellitus.